Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-010057
Filing Date
2023-09-12
Accepted
2023-09-12 11:30:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27632
2 filename2.txt TEXT-EXTRACT 1473
  Complete submission text file 0000000000-23-010057.txt   40520
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filed for) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)